Search Results - "Urist, M"

Kirby I. Bland, M.D.: Opening moves by Urist, Marshall M.

“…First impressions are important, but opening moves can make all the difference. By promptly applying for and being awarded multiple T-32 grants, Kirby enabled…”
Get full text

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System by BALCH, Charles M, SOONG, Seng-Jaw, ATKINS, Michael B, THOMPSON, John A, COIT, Daniel G, BYRD, David, DESMOND, Renee, YUTING ZHANG, LIU, Ping-Yu, LYMAN, Gary H, MORABITO, Aberto, GERSHENWALD, Jeffrey E, THOMPSON, John F, REINTGEN, Douglas S, CASCINELLI, Natale, URIST, Marshall, MCMASTERS, Kelly M, ROSS, Merrick I, KIRKWOOD, John M

“…The American Joint Committee on Cancer (AJCC) recently proposed major revisions of the tumor-node-metastases (TNM) categories and stage groupings for cutaneous…”
Get full text

Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer by MEDINA-FRANCO, Heriberto, VASCONEZ, Luis O, FIX, R. Jobe, HESLIN, Martin J, BEENKEN, Samuel W, BLAND, Kirby I, URIST, Marshall M

“…To examine the incidence of local recurrence (LR) and factors associated with it in a population of patients who underwent skin-sparing mastectomy (SSM) and…”
Get full text

Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm) by Balch, Charles M., Soong, Seng-jaw, Ross, Merrick I., Urist, Marshall M., Karakousis, Constantine P., Temple, Walley J., Mihm, Martin C., Barnhill, Raymond L., Jewell, William R., Wanebo, Harry J., Harrison, Rene

“…BackgroundThis study elucidates the clinical impact of surgical treatment of head and neck squamous cell carcinoma (HNSCC) based on a detailed search of all…”
Get full text

Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma by McMasters, Kelly M, Edwards, Michael J, Ross, Merrick I, Reintgen, Douglas S, Martin, 2nd, Robert C G, Urist, Marshall M, Noyes, R Dirk, Sussman, Jeffrey J, Stromberg, Arnold J, Scoggins, Charles R

“…This analysis was performed to investigate the hypothesis that ulceration predicts improved response to adjuvant interferon (IFN) therapy. Several studies have…”
Get full text

Gender-related differences in outcome for melanoma patients by Scoggins, Charles R, Ross, Merrick I, Reintgen, Douglas S, Noyes, R Dirk, Goydos, James S, Beitsch, Peter D, Urist, Marshall M, Ariyan, Stephan, Sussman, Jeffrey J, Edwards, Michael J, Chagpar, Anees B, Martin, Robert C G, Stromberg, Arnold J, Hagendoorn, Lee, McMasters, Kelly M

“…To better understand the factors associated with the well-established gender difference in survival for patients with melanoma. Gender is an important factor…”
Get full text

Prospective Multi-Institutional Study of Reverse Transcriptase Polymerase Chain Reaction for Molecular Staging of Melanoma by SCOGGINS, Charles R, ROSS, Merrick I, EDWARDS, Michael J, MARTIN, Robert C. G, LEWIS, Angela M, STROMBERG, Arnold J, CONRAD, Andrew J, HAGENDOORN, Lee, ALBRECHT, Jeffrey, MCMASTERS, Kelly M, REINTGEN, Douglas S, NOYES, R. Dirk, GOYDOS, James S, BEITSCH, Peter D, URIST, Marshall M, ARIYAN, Stephan, DAVIDSON, B. Scott, SUSSMAN, Jeffrey J

“…To evaluate the prognostic significance of molecular staging using reverse transcriptase polymerase chain reaction (RT-PCR) in detecting occult melanoma cells…”
Get full text

Bone Morphogenetic Protein: The Molecularization of Skeletal System Development by Urist, Marshall R.

“…Progress in science appears part and parcel with the introduction of new experimental methods. Three landmarks in the history of experimental embryology…”
Get full text

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger by Balch, C M, Soong, S J, Bartolucci, A A, Urist, M M, Karakousis, C P, Smith, T J, Temple, W J, Ross, M I, Jewell, W R, Mihm, M C, Barnhill, R L, Wanebo, H J

“…A prospective multi-institutional randomized surgical trial involving 740 stage I and II melanoma patients was conducted by the Intergroup Melanoma Surgical…”
Get full text

Choosing Wisely Campaign: Radiographic Surveillance in Triple Negative Breast Cancer by Wallace, A.S, Barrett, O.C, De Los Santos, J.F, Forero-Torres, A, Rocque, G, Vaklavas, C, Krontiras, H, Bland, K, Urist, M, Umphrey, H, Bernreuter, W, Keene, K.S

Get full text

A Novel and Accurate Computer Model of Melanoma Prognosis for Patients Staged by Sentinel Lymph Node Biopsy: Comparison with the American Joint Committee on Cancer Model by Callender, Glenda G., MD, Gershenwald, Jeffrey E., MD, FACS, Egger, Michael E., MD, Scoggins, Charles R., MD, MBA, FACS, Martin, Robert C.G., MD, PhD, FACS, Schacherer, Christopher W., PhD, Edwards, Michael J., MD, FACS, Urist, Marshall M., MD, FACS, Ross, Merrick I., MD, FACS, Stromberg, Arnold J., PhD, McMasters, Kelly M., MD, PhD, FACS

“…Background We found that a computer model developed by the American Joint Committee on Cancer (AJCC) melanoma staging committee had limitations for predicting…”
Get full text

T1 and T2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissection by Beenken, Samuel W., Krontiras, Helen, Maddox, William A., Peters, Glenn E., Soong, Seng-jaw, Urist, Marshall M.

“…Background The management of micrometastatic disease from squamous cell carcinoma (SCC) of the oral tongue remains controversial. This study describes…”
Get full text

Role of matrix metalloproteinases in colorectal carcinogenesis by HESLIN, Martin J, JIEMING YAN, JOHNSON, Martin R, WEISS, Heidi, DIASIO, Robert B, URIST, Marshall M

“…To measure coexpression of matrix metalloproteinase (MMP)-2, MMP-7, and MMP-9 genes by real-time quantitative reverse transcriptase-polymerase chain reaction…”
Get full text

Bone morphogenetic protein-2: biology and applications by Riley, E H, Lane, J M, Urist, M R, Lyons, K M, Lieberman, J R

“…Bone morphogenetic protein-2 is a low molecular weight glycoprotein, classified as a morphogen. The sine qua non of bone morphogenetic protein is consistently…”
Get more information

Human bone morphogenetic protein allografting for reconstruction of femoral nonunion by Johnson, E E, Urist, M R

“…A composite inductive allograft consisting of an allogeneic, autolysed, antigen-free cortical bone carrier lyophilized with partially purified human bone…”
Get more information

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial by Wallack, Marc K, Sivanandham, Muthukumaran, Balch, Charles M, Urist, Marshall M, Bland, Kirby I, Murray, Douglas, Robinson, William A, Flaherty, Lawrence, Richards, Jon M, Bartolucci, Alfred A, Rosen, Les

“…Background: A phase III, randomized, double-blind, multicenter trial of active specific immunotherapy (ASI) using vaccinia melanoma oncolysate (VMO) was…”
Get full text

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study by Gillanders, William E, Mikhitarian, Kaidi, Hebert, Renee, Mauldin, Patrick D, Palesch, Yuko, Walters, Christian, Urist, Marshall M, Mann, G Bruce, Doherty, Gerard, Herrmann, Virginia M, Hill, Arnold D, Eremin, Oleg, El-Sheemy, Mohamed, Orr, Richard K, Valle, Alvaro A, Henderson, Michael A, Dewitty, Robert L, Sugg, Sonia L, Frykberg, Eric, Yeh, Karen, Bell, Richard M, Metcalf, John S, Elliott, Bruce M, Brothers, Thomas, Robison, Jay, Mitas, Michael, Cole, David J

“…We sought to establish the clinical relevance of micrometastatic disease detected by reverse transcription polymerase chain reaction (RT-PCR) in axillary lymph…”
Get full text

Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases by Medina-Franco, H, Urist, M M, Fiveash, J, Heslin, M J, Bland, K I, Beenken, S W

“…Merkel cell carcinoma (MCC) is an unusual and potentially aggressive cancer of the skin. There is no consensus regarding the optimal therapeutic approach, and…”
Get full text

Gender-related differences in outcome for melanoma patients by SCOGGINS, Charles R, ROSS, Merrick I, CHAGPAR, Anees B, MARTIN, Robert C. G, STROMBERG, Arnold J, HAGENDOORN, Lee, MCMASTERS, Kelly M, REINTGEN, Douglas S, NOYES, R. Dirk, GOYDOS, James S, BEITSCH, Peter D, URIST, Marshall M, ARIYAN, Stephan, SUSSMAN, Jeffrey J, EDWARDS, Michael J

Get full text

Surveillance after surgical treatment of melanoma: Futility of routine chest radiography by Brown, Russell E., MD, Stromberg, Arnold J., PhD, Hagendoorn, Lee J., MBA, Hulsewede, Deborah Y., CCRC, CCRP, Ross, Merrick I., MD, Noyes, R. Dirk, MD, Goydos, James S., MD, Urist, Marshall M., MD, Edwards, Michael J., MD, Scoggins, Charles R., MD, MBA, McMasters, Kelly M., MD, PhD, Martin, Robert C.G., MD, PhD

“…Background Current recommendations by the National Comprehensive Cancer Network and other groups suggest that follow-up of cutaneous melanoma may include chest…”
Get full text